Bellevue, Wash. – As reported by KOMO, “Senator Patty Murray and Congresswoman Kim Schrier from the state’s 8th district will be in Issaquah on Tuesday talking about prescription drug prices … They will host a roundtable at 1:45 p.m. with seniors from east King County” about the so-called “Inflation Reduction Act” they both voted for.
Here are four questions reporters should ask Senator Murray and Congresswoman Schrier about this bill:
- The so-called “Inflation Reduction Act” has $300 billion less in Medicare spending for seniors and spends tens of billions on hiring IRS agents that would increase investigations on middle class taxpayers. Why did Murray and Schrier vote for less Medicare spending to pay for more IRS agents?
- For Senator Murray: Republicans offered an amendment to this bill to prevent the IRS from auditing those making under $400,000 “to protect low- and middle-income earning American taxpayers from an onslaught of audits from an army of new IRS auditors.” Why did Murray vote against this amendment to protect middle class families from IRS investigations?
- The non-partisan Congressional Budget Office says the prescription drug provisions of the “Inflation Reduction Act” would “increase the launch prices for drugs that are not yet on the market.” Why did Murray and Schrier vote for this bill if it could risk innovation for future treatments and cures?
- For Senator Murray: Republicans offered an amendment to this bill to “protect patients access to current and future treatments for a range of serious conditions, such as cancer, Alzheimer’s disease, HIV/AIDS, Parkinson’s disease, and sickle cell disease, among numerous others.” Why did Murray vote against this amendment to protect patients from higher drug prices and reduced innovation? reporters